Soltis Investment Advisors LLC Purchases 63 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Soltis Investment Advisors LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 582 shares of the medical equipment provider’s stock after purchasing an additional 63 shares during the period. Soltis Investment Advisors LLC’s holdings in Intuitive Surgical were worth $304,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $82,517,000. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Finally, Consolidated Planning Corp increased its position in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $591.65 on Wednesday. The firm has a 50 day moving average price of $555.91 and a 200-day moving average price of $515.92. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Robert W. Baird increased their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.